SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 63 filers reported holding SIERRA ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $542,000 | -1.6% | 317,104 | -24.0% | 0.01% | -20.0% |
Q4 2018 | $551,000 | -57.7% | 417,104 | -45.6% | 0.01% | -37.5% |
Q3 2018 | $1,304,000 | -65.2% | 767,104 | -39.5% | 0.02% | -64.4% |
Q2 2018 | $3,751,000 | -17.8% | 1,267,104 | -42.5% | 0.04% | -21.1% |
Q1 2018 | $4,562,000 | -61.8% | 2,203,704 | -31.2% | 0.06% | -62.3% |
Q4 2017 | $11,950,000 | +108.2% | 3,203,704 | -13.5% | 0.15% | +174.5% |
Q3 2017 | $5,741,000 | +32.5% | 3,703,704 | 0.0% | 0.06% | +22.2% |
Q2 2017 | $4,333,000 | -23.5% | 3,703,704 | 0.0% | 0.04% | -29.7% |
Q1 2017 | $5,667,000 | – | 3,703,704 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 8,112,121 | $13,872,000 | 3.34% |
New Leaf Venture Partners, L.L.C. | 5,020,446 | $8,585,000 | 2.35% |
Abingworth LLP | 1,365,027 | $2,307,000 | 2.06% |
Prosight Management, LP | 2,457,683 | $4,203,000 | 1.84% |
Broadfin Capital, LLC | 4,829,832 | $8,259,000 | 1.70% |
MANGROVE PARTNERS IM, LLC | 3,688,609 | $6,308,000 | 0.84% |
Vivo Capital, LLC | 2,438,270 | $4,169,000 | 0.42% |
683 Capital Management, LLC | 2,313,159 | $3,956,000 | 0.36% |
PA Capital LLC | 138,082 | $236,000 | 0.25% |
ARMISTICE CAPITAL, LLC | 1,560,000 | $2,668,000 | 0.15% |